AtriCure, Inc. (ATRC) vs LeMaitre Vascular, Inc. (LMAT)
- AtriCure, Inc. ATRC 58.55 −4.45%
- LeMaitre Vascular, Inc. LMAT 80.60 −3.46%
AtriCure, Inc. and LeMaitre Vascular, Inc. are both Medical Instruments & Supplies companies. AtriCure, Inc. is the larger, with a market value of $3.1B against $1.9B — 1.6× the size. LeMaitre Vascular, Inc. trades at the lower P/E: 29.7× against 199×. AtriCure, Inc. grew revenue faster over the last twelve months: 13.8% against 11.8%. LeMaitre Vascular, Inc. has the higher net margin (23.5% vs 2.52%) and the higher return on invested capital (22.1% vs 2.61%). Across the 22 metrics below, LeMaitre Vascular, Inc. leads on 14 and AtriCure, Inc. on 8.
Valuation
Profitability
| Metric | ATRC | LMAT | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 76.74% | 72.04% | 53.60% |
| Operating margin | 2.89% | 27.73% | 1.97% |
| Net margin | 2.52% | 23.51% | 0.00% |
| Free cash flow margin | 8.98% | 24.87% | 2.36% |
| Return on equity | 2.95% | 15.62% | 0.00% |
| Return on assets | 2.20% | 10.10% | 0.00% |
| Return on invested capital | 2.61% | 22.05% | 0.13% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack